September 12, 2019

V-Wave Receives Second FDA Breakthrough Device Designation: Interatrial Shunt for Pulmonary Arterial Hypertension

September 5, 2019

FTC clears $1.1B Corindus buyout by Siemens Healthineers

August 15, 2019

V-Wave's Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart Failure

August 8, 2019

Germany’s Siemens Healthineers buys US firm Corindus for $1.1 billion

July 30, 2019

TransMedics Announces Successful Long Distance Retrieval and Transplantation of Donor Lungs from Hawaii Using Organ Care System (OCS™)

July 23, 2019

Corindus Vascular Robotics Reached An Inflection Point

July 14, 2019

BioStar Capital Expands VC Fund to $91 Million

June 3, 2019

TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage

May 16, 2019

Corindus Vascular Robotics: One CEO On Commercializing Healthcare’s Next Big Thing

January 16, 2019

Vytronus featured in MedTech Strategist: "Vytronus Poised to Offer the First Personalized Therapy Approach to Cardiac Ablation"

January 14, 2019

Trice Medical Closes $18.3 Million Series C Extension

January 3, 2019

Ablative Solutions, Inc. Announces $77 Million Financing for Unique Therapeutic Approach to Treating Uncontrolled Hypertension

December 6, 2018

Corindus’ Technology Successfully Used in World’s First-in-Human Telerobotic Coronary Intervention

September 24, 2018

Aria CV Wins TCT 2018 Shark Tank Competition

September 24, 2018

CathWorks FFRangio™ Trial Meets Primary Endpoint and Exceeds Performance Goals

August 22, 2018

CathWorks FFRangio™ System Files FDA 510(k) Submission

July 11, 2018

CathWorks Receives CPT Code for New Wire-Free, Intraprocedural FFR Measurements to Optimize PCI Therapy Decisions

April 26, 2018

V-Wave Closes $70M Financing to Support Pivotal Study of its Heart Failure Therapy

April 12, 2018

TransMedics, Inc. Receives FDA Pre-Market Approval (PMA) for its OCS™ Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation

March 21, 2018

OrthoSpace Completes Enrollment for InSpace™ U.S. Pivotal Study

March 16, 2018

Corindus Announces $25 Million Private Placement of Series A Convertible Preferred Shares and Warrants

September 12, 2019

V-Wave Receives Second FDA Breakthrough Device Designation: Interatrial Shunt for Pulmonary Arterial Hypertension

March 6, 2018

Beaumont Hospital, Troy Adds Robotics Catheterization System for Improved Safety

March 5, 2018

Corindus Receives FDA Clearance for First Automated Robotic Movement in technIQ™ Series for CorPath GRX Platform

February 20, 2018

Corindus Receives FDA Clearance for CorPath® GRX System in Peripheral Vascular Interventions

January 23, 2018

Corindus to Co-Sponsor Courses at Multiple Leading Healthcare Institutions on Value-based Interventional Procedural Training

January 2, 2018

Corindus to Participate with Mayo Clinic in Preclinical Study of Remote Control Robotics for Percutaneous Coronary Interventions Remote Treatment Capabilities

December 14, 2017

Cibiem Appoints William H. Kucheman to the Board of Directors

December 14, 2017

Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.

November 28, 2017

Surgeons perform region's 1st 'liver in a box' transplant

November 15, 2017

Angiography Image-based FFR May Eliminate Need for Pressure Wires (CathWorks Ltd. - TCT 2017)

October 2, 2017

CathWorks Announces Completion of $15.8M Series B Financing

September 6, 2017

6 Ways Robots Will Be the Medical Assistants of Tomorrow

August 6, 2017

Why Ablative Solutions is rooting for its biggest competitor

July 6, 2017

OrthoStreams: 6 Questions with Jeff O’Donnell, who is leading Trice Medical, a disruptive orthopedic startup with an office-based arthroscopy device

June 6, 2017

Trice Medical Closes $19.3 Million Series C Financing To Address Increased Demand For Mi-Eye

June 2, 2017

Corindus Vascular Robotics, Inc. releases CorPath Monthly Newsletter for May 2017

May 13, 2017

Heart Rhythm 2017: Late-breaking clinical trial discussion with Petr Neuzil, MD, PhD on the NewPace Ltd. first-in-man study

May 12, 2017

NewPace Ltd. conducts first-in-man study, proving feasibility of implanting the first-ever, string-shaped rechargeable defibrillation device

May 1, 2017

Trice Medical, Inc. featured in the Philadelphia Inquirer: 

With Philly's scene maturing, the search is on again for more Stellar Startups

March 31, 2017

Corindus Vascular Robotics Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath® GRX System

March 16, 2017

Corindus Vascular Robotics Announces Closing of Private Placement for $45 Million

Louis A. Cannon, M.D. Appointed to Corindus Board of Directors

March 3, 2017

Leading Orthopedic Surgeon Dr. Calvin Johnson Announces a New Diagnosis and Treatment Option: The mi-eye 2 from Trice Medical

February 28, 2017

Corindus Vascular Robotics Announces Private Placement for $45 Million

February 16, 2017

This Needle Cam Can Diagnose Joint Injuries Without an MRI: Trice Medical, Inc.

February 2, 2017

Trice Medical, Inc. and Pacific Medical, Inc. announce multi-state distribution agreement

January 4, 2017

OrthoSpace Announces Publication of Positive Long-Term Follow-Up Data for InSpaceTM System for the Treatment of Massive Rotator Cuff Tears

January 3, 2017

DePuy Synthes Acquires Interventional Spine Expandable Cage Technology to Accelerate Growth in Spine

December 22, 2016

OrthoStreams: Keep your eye on Trice Medical!

December 21, 2016

Orthopedics This Week: Trice Medical's In-Office Arthroscope for Knees, Shoulders

December 19, 2016

Conventus Orthopaedics announces milestone of 700+ Cage implantations

December 9, 2016

Tiny HD Cameras Have Revolutionized Knee Surgery: Trice Medical's Mi-Eye 2 Device Featured on CBS New York

December 1, 2016

OrthoSpace Completes Equity Financing Round

October 10, 2016

Professor Ian Meredith, Cardiovascular Medical Venture Partner for BioStar, To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer

October 7, 2016

Top 10 Largest Medical Device Exits Since 2012: Acquisition of Ellipse Technologies, Inc. by NuVasive, Inc. listed at #9 (CB Insights)

October 6, 2016

Trice Medical Receives FDA 510(k) Clearance for mi-eye 2

September 29, 2016

Dr. Jason Hunt, orthopedic surgeon and sports medicine expert at Kaizen Orthopedics in Tampa, FL, discusses Trice Medical's cutting-edge mi-eye technology for immediate diagnosis of knee injury without the need for MRI

September 13, 2016

FDA Allows Ablative Solutions to Initiate its Phase 2 TARGET-BP I Trial of Combination Drug/Device Therapy for Hypertension under its IND

September 11, 2016

Alcohol denervation technology developed by Ablative Solutions, Inc. is of particular interest in the field of renal denervation (MedPage Today | Cardiology)

August 16, 2016

MI EYE: TREATING JOINT PROBLEMS WITHOUT MRI

(ABC News WPVI-TV)

August 15, 2016

Zimmer Biomet Strengthens Musculoskeletal Diagnostic Offering with Acquisition of CD Diagnostics

August 15, 2016

Conventus Orthopaedics, Inc.: Distal Radial Fracture Management With an Intramedullary Cage and Fragment Fixation (The Journal of Hand Surgery)

August 14, 2016

Heartwarming Story: Developing a Better Way to Preserve Organs

(Newsweek)

July 29, 2016

VytronUS, Inc. Raises $49 Million in Series C Financing

July 26, 2016

New Device Gives Real-Time Answers for Joint Injuries

July 21, 2016

EuroPCR 2016 Hot Line: Alcohol-mediated endovascular renal denervation (The PEREGRINE study)

July 10, 2016

Crain's Detroit Business:  BioStar shines bright in venture capital sky

June 10, 2016

CNN Vital Signs:  TransMedics device keeps organs alive outside the body

May 26, 2016

TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy

March 28, 2016

First Human Results with V-Wave’s Interatrial Shunt Published in The Lancet : Early Experience in Class III Heart Failure Patients was Favorable

March 2, 2016

Conventus Orthopaedics, Inc. Case Study:  Minimally Invasive Approach Could Reduce Complications Associated With Wrist Fractures (CBS2 New York)

February 16, 2016

Ablative Solutions Announces First Two Patients Treated in the European Peregrine Post-Market Study for Renal Denervation

February 9, 2016

Conventus Orthopaedics, Inc. Case Study:  Successful Fracture Repair Using Groundbreaking Proximal Humerus Device Featured on WIVB News

January 26, 2016

BioStar Listed as a Top 10 Medical Device VC Investor in the Silicon Valley Bank Trends in Healthcare Investments and Exits Annual Report

January 11, 2016

V-Wave Ltd. Announces $28M Series B Financing

January 5, 2016

NuVasive Inc. to Acquire Ellipse Technologies in $410 Million Deal

January 4, 2016

Conventus Orthopaedics, Inc. Appoints New Board Member with 35+ Years of Medical Device Industry Experience

December 15, 2015

Ellipse Technologies, Inc. Case Study:  Successful Limb-Lengthening for Congenital Fibular Hemimelia Using PRECICE (Detroit Medical Center)

December 2, 2015

Ablative Solutions, Inc. adds Dr. Gregg W. Stone, Cardiovascular Medical Venture Partner for BioStar Ventures, to its Scientific Advisory Board

November 5, 2015

Why Health Care Start-Ups Need Investing Expertise

November 3, 2015

Autonomix Medical:  New Approaches to Denervation Therapy (TCT 2015)

October 19, 2015

Ellipse Tech files for up to $75M IPO to back magnetically adjustable orthopedic implants

September 28, 2015

BioStar Director Dr. David Brophy Listed in the Top 25 of Crain's Most Connected

August 26, 2015

Conventus Orthopaedics Announces First Surgeries for Conventus PH Cage™, Proximal Humerus Implant Device in United States and Europe

July 15, 2015

Aria CV, Inc. Closes on $7.8 million Series A Financing

July 9, 2015

BioStar Ventures raises almost $70M for third early stage, med tech fund

July 6, 2015

OrthoSpace Enrolls First Patients in US IDE Study

June 22, 2015

Ellipse Technologies’ PRECICE® Limb Length Discrepancy Technology Used to Treat 2000th Patient